The Emerging Risk of Peptides in Supplements LegitScript FDA Targets GLP 1 and Peptide Compounding, Advertising and 'Research Use Only' Labeling FDA Is Expected to Lift Restriction on Peptides, Heeding RFK Jr.'s Wishes The New York Times Big FDA review coming this July. Here's what athletes and patients should know about BPC 157, TB 500, and the broader peptide conversation. Always speak with your physician before starting any new protocol. #bpc157 # Is BPC 157 Banned? Oral vs. Injectable Forms Explained